Scinovex
article Open AccessTop 1% cited

<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology

Epilepsia · 2017 · Vol. 58(4) · pp. 512–521
Ingrid E. SchefferSamuel F. BerkovicGiuseppe CapovillaMary ConnollyJacqueline A. FrenchLaura Maria de Figueiredo Ferreira GuilhotoÉdouard HirschSanjeev JainGary W. MathernSolomon L. MoshéDouglas R. NordliEmilio PeruccaTorbjörn TomsonSamuel WiebeYuehua ZhangSameer M. Zuberi

Abstract

The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary purpose is for diagnosis of patients, but it is also critical for epilepsy research, development of antiepileptic therapies, and communication around the world. The new classification originates from a draft document submitted for public comments in 2013, which was revised to incorporate extensive feedback from the international epilepsy community over several rounds of consultation. It presents three levels, starting with seizure type, where it assumes that the patient is having epileptic seizures as defined by the new 2017 ILAE Seizure Classification. After diagnosis of the seizure type, the next step is diagnosis of epilepsy type, including focal epilepsy, generalized epilepsy, combined generalized, and focal epilepsy, and also an unknown epilepsy group. The third level is that of epilepsy syndrome, where a specific syndromic diagnosis can be made. The new classification incorporates etiology along each stage, emphasizing the need to consider etiology at each step of diagnosis, as it often carries significant treatment implications. Etiology is broken into six subgroups, selected because of their potential therapeutic consequences. New terminology is introduced such as developmental and epileptic encephalopathy. The term benign is replaced by the terms self-limited and pharmacoresponsive, to be used where appropriate. It is hoped that this new framework will assist in improving epilepsy care and research in the 21st century.

Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesNeuroscience and Neuropharmacology ResearchEpilepsyTerminologyEtiologyMedicineEpilepsy syndromesGeneralized epilepsyPediatricsIntensive care medicinePsychiatry

MeSH terms

EpilepsyHumansInternational AgenciesTerminology as Topic

Funding

  • U.S. Department of Defense
  • March of Dimes Foundation
  • CURE Childhood Cancer
  • Citizens United for Research in Epilepsy
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Sanofi
  • Takeda Pharmaceuticals U.S.A.
  • Sunovion
  • Vertex Pharmaceuticals
  • Dravet Syndrome UK
  • Zogenix
  • Ultragenyx Pharmaceutical
  • Alva Foundation
  • GW Pharmaceuticals
  • Acorda Therapeutics
  • Sage Therapeutics
  • Zynerba Pharmaceuticals
  • Supernus Pharmaceuticals
  • Mylan
  • NeuroPace
  • Upsher-Smith
  • Epilepsy Research UK
  • Lundbeckfonden
  • Eisai
  • Stockholms Läns Landsting
  • Fundação Bial
  • Universidade Católica de Brasília
  • Yorkhill Children’s Charity
  • H. Lundbeck A/S
  • Sun Pharma
  • Epilepsiatutkimussäätiö
  • National Institutes of Health
  • Humanities Research Center, Rice University
  • University of California, Los Angeles
  • Canadian Institutes of Health Research
  • Medical Research Council
  • National Health and Medical Research Council
  • National Institute of Neurological Disorders and Stroke
  • UCB Pharma
  • Division of Arctic Sciences
  • Cilag
Citations
4,758
FWCI
250.47
field-weighted impact
References
60
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.